Clinical Trial Update: TLC D-99 and Ifosfamide in Metastatic Soft Tissue Sarcoma Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating TLC D-99 in combination with Ifosfamide for metastatic soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)
• TLC D-99

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Sarcoma, Soft Tissue | Phase 1, Phase 2 | Status: COMPLETED